SIGA Technologies (SIGA) Competitors $6.13 -0.07 (-1.13%) Closing price 04:00 PM EasternExtended Trading$6.10 -0.04 (-0.57%) As of 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SIGA vs. AGIO, GLPG, IRON, IDYA, INDV, EWTX, JANX, EVO, IMCR, and MESOShould you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Agios Pharmaceuticals (AGIO), Galapagos (GLPG), Disc Medicine (IRON), IDEAYA Biosciences (IDYA), Indivior (INDV), Edgewise Therapeutics (EWTX), Janux Therapeutics (JANX), Evotec (EVO), Immunocore (IMCR), and Mesoblast (MESO). These companies are all part of the "pharmaceutical products" industry. SIGA Technologies vs. Agios Pharmaceuticals Galapagos Disc Medicine IDEAYA Biosciences Indivior Edgewise Therapeutics Janux Therapeutics Evotec Immunocore Mesoblast SIGA Technologies (NASDAQ:SIGA) and Agios Pharmaceuticals (NASDAQ:AGIO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Do analysts recommend SIGA or AGIO? Agios Pharmaceuticals has a consensus price target of $56.00, indicating a potential upside of 85.98%. Given Agios Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Agios Pharmaceuticals is more favorable than SIGA Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SIGA Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Agios Pharmaceuticals 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56 Is SIGA or AGIO more profitable? Agios Pharmaceuticals has a net margin of 1,845.92% compared to SIGA Technologies' net margin of 49.33%. SIGA Technologies' return on equity of 49.06% beat Agios Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets SIGA Technologies49.33% 49.06% 38.72% Agios Pharmaceuticals 1,845.92%-2.51%-2.26% Which has preferable earnings and valuation, SIGA or AGIO? Agios Pharmaceuticals has lower revenue, but higher earnings than SIGA Technologies. Agios Pharmaceuticals is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSIGA Technologies$120.33M3.64$68.07M$0.679.15Agios Pharmaceuticals$37.04M47.09$673.72M$11.242.68 Which has more volatility & risk, SIGA or AGIO? SIGA Technologies has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Agios Pharmaceuticals has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Does the media refer more to SIGA or AGIO? In the previous week, Agios Pharmaceuticals had 6 more articles in the media than SIGA Technologies. MarketBeat recorded 11 mentions for Agios Pharmaceuticals and 5 mentions for SIGA Technologies. Agios Pharmaceuticals' average media sentiment score of 1.41 beat SIGA Technologies' score of 0.72 indicating that Agios Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SIGA Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agios Pharmaceuticals 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in SIGA or AGIO? 55.4% of SIGA Technologies shares are owned by institutional investors. 1.5% of SIGA Technologies shares are owned by insiders. Comparatively, 4.3% of Agios Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer SIGA or AGIO? Agios Pharmaceuticals received 487 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 66.76% of users gave Agios Pharmaceuticals an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote. CompanyUnderperformOutperformSIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% Agios PharmaceuticalsOutperform Votes49266.76% Underperform Votes24533.24% SummaryAgios Pharmaceuticals beats SIGA Technologies on 12 of the 18 factors compared between the two stocks. Get SIGA Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$437.93M$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio5.118.9226.8419.71Price / Sales3.64250.95391.39116.98Price / Cash6.3465.8538.2534.62Price / Book2.216.466.794.50Net Income$68.07M$143.98M$3.23B$248.18M7 Day Performance3.37%3.04%4.07%1.14%1 Month Performance2.68%7.44%12.52%15.20%1 Year Performance-18.92%-2.46%16.83%6.56% SIGA Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASIGA Technologies1.3585 of 5 stars$6.13-1.1%N/A-17.9%$437.93M$120.33M5.1140AGIOAgios Pharmaceuticals3.9927 of 5 stars$29.14+6.7%$56.00+92.2%-9.1%$1.69B$37.04M2.57390Positive NewsAnalyst DowngradeGLPGGalapagos0.4794 of 5 stars$25.07-1.0%$25.33+1.1%-1.0%$1.65B$288.19M0.001,310News CoveragePositive NewsIRONDisc Medicine2.9064 of 5 stars$46.61+5.4%$98.80+112.0%+54.7%$1.61BN/A-11.7130IDYAIDEAYA Biosciences3.7852 of 5 stars$18.35+5.3%$53.58+192.0%-51.3%$1.61B$7M-5.5680Positive NewsINDVIndivior3.28 of 5 stars$11.34+2.3%$15.00+32.3%-33.1%$1.56B$1.17B-32.401,164News CoveragePositive NewsEWTXEdgewise Therapeutics2.9231 of 5 stars$14.82+1.6%$40.22+171.4%-20.8%$1.55BN/A-9.8860Positive NewsJANXJanux Therapeutics2.7447 of 5 stars$26.06+2.0%$95.25+265.5%-47.1%$1.54B$10.59M-22.2730Positive NewsEVOEvotec1.4939 of 5 stars$4.17-3.0%$5.93+42.3%-21.9%$1.48B$788.22M0.004,200Positive NewsIMCRImmunocore2.9167 of 5 stars$29.54+4.0%$58.13+96.8%-39.1%$1.48B$310.20M-31.09320Positive NewsMESOMesoblast1.8344 of 5 stars$11.35+3.5%$18.00+58.6%+57.9%$1.45B$5.67M0.0080Gap Down Related Companies and Tools Related Companies Agios Pharmaceuticals Alternatives Galapagos Alternatives Disc Medicine Alternatives IDEAYA Biosciences Alternatives Indivior Alternatives Edgewise Therapeutics Alternatives Janux Therapeutics Alternatives Evotec Alternatives Immunocore Alternatives Mesoblast Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIGA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SIGA Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SIGA Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SIGA Stock Free SIGA Stock Alerts